News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,347 Results
Type
Article (38861)
Company Profile (248)
Press Release (640238)
Section
Business (203601)
Career Advice (1987)
Deals (35357)
Drug Delivery (78)
Drug Development (80627)
Employer Resources (167)
FDA (16021)
Job Trends (14786)
News (343824)
Policy (32411)
Tag
Academia (2532)
Africa (714)
Alliances (48996)
Alzheimer's disease (1146)
Approvals (15943)
Arizona (174)
Artificial intelligence (69)
Asia (36821)
Australia (5988)
Bankruptcy (350)
Best Places to Work (11289)
Biosimilars (63)
Biotechnology (177)
C2C Services and Suppliers (78810)
California (1885)
Canada (937)
Cancer (492)
Career advice (1655)
Cell therapy (121)
China (150)
Clinical research (63230)
Collaboration (139)
Colorado (79)
Compensation (81)
Connecticut (75)
COVID-19 (2489)
Cystic fibrosis (73)
Data (312)
Diabetes (81)
Diagnostics (5974)
Drug pricing (63)
Earnings (83658)
Employer resources (142)
Europe (78660)
Events (107842)
Executive appointments (153)
FDA (16248)
Florida (266)
Funding (148)
Gene therapy (92)
GLP-1 (510)
Government (4292)
Healthcare (18631)
Hotbed/Location (481061)
Illinois (255)
Indiana (147)
Infectious disease (2518)
Inflammatory bowel disease (91)
Interviews (309)
IPO (16209)
Job creations (3620)
Job search strategy (1418)
Kansas (94)
Layoffs (393)
Legal (7831)
Lung cancer (110)
Manufacturing (86)
Maryland (398)
Massachusetts (1529)
Medical device (13050)
Medtech (13055)
Mergers & acquisitions (19021)
Metabolic disorders (247)
Michigan (124)
Minnesota (214)
Neuroscience (1291)
New Jersey (580)
New York (596)
NextGen Class of 2024 (6487)
Non-profit (4461)
North Carolina (588)
Northern California (825)
Obesity (146)
Ohio (104)
Opinion (172)
Patents (74)
Pennsylvania (581)
People (55865)
Pharmaceutical (60)
Phase I (19590)
Phase II (27846)
Phase III (20806)
Pipeline (112)
Postmarket research (2547)
Preclinical (8317)
Press Release (65)
Rare diseases (130)
Real estate (5885)
Recruiting (63)
Regulatory (21200)
Research institute (2308)
Resumes & cover letters (347)
South America (1088)
Southern California (766)
Startups (3564)
Texas (240)
United States (8576)
Vaccines (475)
Washington State (253)
Weight loss (127)
Date
Today (121)
Last 7 days (641)
Last 30 days (2444)
Last 365 days (37135)
2024 (26211)
2023 (40087)
2022 (51183)
2021 (55729)
2020 (54116)
2019 (46572)
2018 (35038)
2017 (32123)
2016 (31500)
2015 (37570)
2014 (31330)
2013 (26353)
2012 (28580)
2011 (29274)
2010 (27334)
679,347 Results for "envision inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Envision Pharma Group Announces the Appointment of Alistair Macdonald to Board of Directors
Envision Pharma Group announced the appointment of Alistair Macdonald to the Envision Board of Directors.
May 8, 2024
·
2 min read
Business
Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer
Envision Pharma Group (Envision) has appointed Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team.
January 18, 2024
·
2 min read
Press Releases
Envision Pharma Group Announces the Appointment of Bill Shirey to President of Life Science Commercialization
July 30, 2024
·
2 min read
Business
Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)
Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) and a member of its Executive Leadership Team.
January 16, 2024
·
2 min read
FDA
UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC
UroGen Pharma Ltd. announced 82.3% 12-month duration of response data by Kaplan-Meier estimate from its Phase 3 ENVISION trial in patients who achieved complete response at three months after the first instillation of investigational drug UGN-102 for intravesical solution.
June 13, 2024
·
8 min read
Business
Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
Envision Pharma Group unveils its AI Innovation Board and announces the appointment of Dr. Loubna Bouarfa as AI thought leader and Chairwoman of the newly established board.
November 15, 2023
·
2 min read
Business
Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
Envision Pharma Group (Envision) today announced the appointment of Dr. Deepti Sodhi Jaggi to the Envision Board of Directors.
May 9, 2023
·
2 min read
Business
Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
Envision Pharma Group (Envision) has appointed Tino Quintero to the role of General Manager/VP of Market Access & Customer Insights.
May 1, 2023
·
2 min read
Business
Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
Envision Pharma Group (Envision) has appointed Dr. Jennifer Costello, PharmD, BCPS, CMPP, to the role of Chief Medical Officer.
May 4, 2023
·
3 min read
Business
UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced financial results for the first quarter ended March 31, 2024, and provided an overview of recent developments.
May 13, 2024
·
17 min read
1 of 67,935
Next
